Close
 |
Algeria |
|
Angola |
|
Benin |
|
Botswana |
|
Burkina Faso |
|
Burundi |
|
Cameroon |
|
Cape Verde |
|
Central African Republic |
|
Chad |
|
Comoros |
|
Congo |
|
Côte d’Ivoire |
|
Djibouti |
|
DRC |
|
Egypt |
|
Equatorial Guinea |
|
Eritrea |
|
Eswatini |
|
Ethiopia |
|
Gabon |
|
Gambia |
|
Ghana |
|
Guinea |
|
Guinea-Bissau |
|
Kenya |
|
Lesotho |
|
Liberia |
|
Libya |
|
Madagascar |
|
Malawi |
|
Mali |
|
Mauritania |
|
Mauritius |
|
Morocco |
|
Mozambique |
|
Namibia |
|
Niger |
|
Nigeria |
|
Rwanda |
|
SADR |
|
São Tomé and Príncipe |
|
Senegal |
|
Seychelles |
|
Sierra Leone |
|
Somalia |
|
South Africa |
|
South Sudan |
|
Sudan |
|
Tanzania |
|
Togo |
|
Tunisia |
|
Uganda |
|
Zambia |
|
Zimbabwe |
|
Maternal, Newborn, Child and Adolescent Health |
|
Life expectancy at birth |
|
Maternal mortality ratio |
|
Stillbirth rate |
|
Neonatal mortality rate |
|
Infant mortality rate |
|
Under 5 mortality rate |
|
Antenatal care coverage: 4+ visits |
|
Antenatal care coverage: 8+ visits |
|
Births attended by skilled health personnel |
|
Postpartum care coverage for mothers |
|
Postnatal care coverage for newborns |
|
Exclusive breastfeeding for infants under 6 months |
|
Coverage of first dose of measles vaccination |
|
Stunting - short height for age under age 5 |
|
Wasting – low weight for height under age 5 |
|
Overweight - heavy for height under 5 |
|
Sexual and Reproductive Health |
|
Child marriage before age 15 |
|
Child marriage before age 18 |
|
Female genital mutilation |
|
Sexual violence by age 18 - female |
|
Sexual violence by age 18 - male |
|
Very early child bearing under age 16 |
|
Adolescent birth rate ages 15 to 19 |
|
Contraceptive prevalance rate, modern methods, all women |
|
Demand satisfied for modern contraception |
|
Communicable Diseases |
|
New HIV infections |
|
Antiretroviral treatment coverage |
|
Preventing mother-to-child transmission of HIV |
|
Condom use |
|
New TB infections |
|
New malaria infections |
|
Non-Communicable Diseases |
|
Mortality from non-communicable diseases |
|
Suicide mortality rate |
|
Current tobacco use among females aged 15 and over |
|
Current tobacco use among males aged 15 and over |
|
Harmful alcohol use aged 15 and over |
|
Health Financing |
|
External health expenditure as % current health expenditure |
|
Government health expenditure as % current health expenditure |
|
Government health expenditure as % GDP |
|
Government health expenditure as % general govt expenditure |
|
Government health expenditure per capita |
|
Out-of-pocket health expenditure as % of current health expenditure |
|
Percentage of national health budget allocated for reproductive health |
|
Health systems and policies |
|
Density of health workers - physicians |
|
Density of health workers - nurses and midwives |
|
Density of health workers - pharmaceutical staff |
|
Qualified obstetricians |
|
Birth registration |
|
At least basic drinking water |
|
At least basic sanitation services |
|
Open defecation |
|
Implementation of AMRH Initiative |
| Full Name: | Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of mother-to-child transmission of HIV |
| Full Unit: | Percentage, % |
| Year-range of Data: | 2017 |
| Source: | UNAIDS AIDSinfo |
| Link to Source: | http://aidsinfo.unaids.org/ |
| Date Source Published: | July 2018 |
| Date Source Accessed: | 31st January 2019 |
 |
The following countries had no data: |
The indicator measures the percentage of pregnant women living with HIV who received antiretroviral medicine among the estimated number of pregnant women living with HIV, to reduce the risk of mother-to-child transmission (PMTCT) of the virus.
Providing antiretroviral medicines (as lifelong therapy or as prophylaxis) for the mother during pregnancy and delivery can significantly reduce the risk of mother-to-child transmission. This indicator allows countries to monitor the coverage of provision of antiretroviral medicines to pregnant women living with HIV to reduce the risk of transmitting HIV to infants during pregnancy and delivery. Since the indicator usually measures the antiretroviral medicines dispensed and not those consumed, adherence to the regimen cannot be determined in most cases. This entails antiretroviral medicine prophylaxis for the infant and antiretroviral medicines for the mother or child if breastfeeding and using safe delivery practices and safer infant feeding. The data will be used to track progress towards global and national goals of eliminating mother-to-child transmission; to inform policy and strategic planning; for advocacy; and for leveraging resources for accelerating scale-up.
Two pieces of information are needed: 1) number of pregnant women living with HIV who gave birth and received antiretroviral medicine during the past 12 months and 2) estimated number of pregnant women living with HIV who gave birth during the past 12 months. The first is obtained from monitoring tools used by programmes, such as patient registers and summary reporting forms. The second from surveys used for the surveillance of antenatal clinics in conjunction with demographic data, or estimation models such as Spectrum. Using these two estimates, the indicator is calculated by dividing the number of HIV-positive pregnant women who received antiretrovirals in the past 12 months by the number of HIV-positive pregnant women in the past 12 months.
Close
More about indicator and sources
This indicator allows countries to monitor the coverage of provision of antiretroviral medicines to pregnant women living with HIV to reduce the risk of transmitting HIV to infants during pregnancy and delivery. Since the indicator usually measures the antiretroviral medicines dispensed and not those consumed, adherence to the regimen cannot be determined in most cases.
Figures which are reported as > 95% for this indicator on the UNAIDS AIDSinfo database are shown on this African Health Stats platform as 95% for the following countries: Benin (2016); Botswana (2010, 2011, 2013, 2015, 2016); Cape Verde (2015, 2016, 2017); Eswatini (2011, 2014); Gamiba (2012); Guinea-Bissau (2014); Lesotho (2011); Namibia (2017); South Africa (2014,2016, 2017); Uganda (2014-2017); Tanzania (2012); Zambia (2010, 2011) and Zimbabwe (2017). Where the value was reported as <1% on the UNAIDS AIDSinfo database in Somalia (2010) is shown on AHStats as 0.9%.
For more information, download the Global AIDS Response Progress Report 2017: http://www.unaids.org/en/resources/documents/2017/2017_data_book [/ link]
More information on calculations
The numerator for this indicator is estimated number of women living with HIV who delivered within the past 12 months. For the numerator, the method of measurement from national programme records aggregated from programme monitoring tools, such as patient registries and summary reporting forms.
The denominator for this indicator is the number of pregnant women living with HIV who delivered during the past 12 months and received antiretroviral medicines to reduce the risk of the mother-to-child transmission of HIV. Global reports summarizing the coverage of antiretroviral medicine for preventing mother-to-child transmission will exclude women who received single-dose nevirapine, since it is considered a suboptimal regimen. However, the country should report the number of women who only received single-dose nevirapine. For the denominator, estimation models such as Spectrum or antenatal clinic surveillance surveys combined with demographic data and appropriate adjustments related to the coverage of antenatal clinic surveys.
See also the UNAIDS website on HIV data and estimates, including information on methodology, visit:
https://www.unaids.org/sites/default/files/media_asset/2017-Global-AIDS-Monitoring_en.pdf
